The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis ...

The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...

U.S. health officials knew about the risks of myocarditis from COVID-19 vaccines but downplayed the concern and delayed ...

The updated warnings highlight a rare risk of heart inflammation in teen boys and young men, CBS News reported. The warning ...

The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.

For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

The Food and Drug Administration is telling Pfizer and Moderna to expand the warning labels on their COVID-19 vaccines about the risk of a possible heart injury side effect linked to the mRNA ...

The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart ...

U.S. health officials knew about the risks of myocarditis from COVID-19 vaccines but downplayed the ... to cases of myocarditis — a type of heart inflammation — following COVID-19 vaccination.